We can't find the internet
Attempting to reconnect
25390.2 PFLS-LS
Modelling and preclinical verification of a diagnostic and therapeutic approach to treat microvascular obstructions in heart attack patients.
Zusammenfassung
Modelling and preclinical verification of a diagnostic and therapeutic approach to treat microvascular obstructions in heart attack patients.
Weitere Texte
Abstract
A major cardiovascular unmet medical need today is the peri#procedural diagnosis and treatment of microvascular obstructions (MVO). MVO occurs in 40% # 60% of acute myocardial infarction with STsegment elevations patients treated with a stent. Current therapeutic options remain limited with non#standardized approaches attempting to clear the MVO#s. ReFlow Therapeutics aims at developing the first diagnostic and therapeutic medical device that can diagnose and treat MVO while the patient is still in the catheter laboratory after a stent.
Beteiligte
Dominik Obrist
Kontaktperson
dominik.obrist@artorg.unibe.ch
Universität Bern ARTORG Center Dominik Obrist Murtenstrasse 50 3008 Bern BE CH
Jon H. Hoem
Wirtschaftspartner
jhoem@reflow-therapeutics.ch
ReFlow Therapeutics AG Jon H. Hoem Neuhofstrasse 5a 6340 Baar ZG CH
Projektdetails
- Forschungsstelle
- INNOSUISSE
- Projektstatus
- Abgeschlossen
- Projekttyp
- Forschungsprojekt
- Startdatum
- 2017-02-28
- Enddatum
- 2018-08-31
- Bewilligte Gesamtkosten
- CHF 823925.00
- Sektion
- 20 Förderbereich Life Sciences
- NABS Politikbereich
- Industrielle Produktivität und Technologie
Forschungsdisziplinen
- T115 Medical technology 100.0%